LEADER 03452nam  22006015  450 
001 9910300297103321
005 20200705230539.0
010   $a3-319-62506-3
024 7 $a10.1007/978-3-319-62506-5
035   $a(CKB)4100000001795020
035   $a(DE-He213)978-3-319-62506-5
035   $a(MiAaPQ)EBC5240731
035   $a(PPN)223957550
035   $a(EXLCZ)994100000001795020
100   $a20180123d2018      u|         0
101 0 $aeng
135   $aurnn|008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aAtlas of Thyroid and Neuroendocrine Tumor Markers /$fedited by Luca Giovanella
205   $a1st ed. 2018.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2018.
215   $a1 online resource (XII, 249 p. 41 illus., 30 illus. in color.) 
311   $a3-319-62505-5 
320   $aIncludes bibliographical references at the end of each chapters.
330   $aThis book highlights the increase in thyroid tumors and NET and demonstrates the growing importance of circulating markers in diagnosis as well as treatment and follow-up. Dramatic technical improvements have heightened the clinical impact of well-established, conventional biochemical markers. In addition, more recent genetic and molecular approaches have provided innovative molecular markers. In this context, effective communication between clinicians and laboratory physicians/scientists is essential in allowing all those involved to fully profit from these exciting advances.  In this comprehensive, up-to-date book, authors from different laboratory and clinical areas link laboratory and clinical topics. Analytical problems such as interferences, false-negative and false-positive results are discussed in depth, and flow-charts offer insights into identifying and avoiding them. Illustrated clinical cases detail the clinical role and limitations of different tumor markers. Lastly, it explores health technology assessment and economic issues. This is a valuable resource for endocrinologists, oncologists, nuclear medicine physicians, scientists and technologists who want to keep abreast of the latest developments.
606   $aEndocrinology
606   $aDiagnosis, Laboratory
606   $aNuclear medicine
606   $aRadiotherapy
606   $aPathology
606   $aEndocrinology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33053
606   $aLaboratory Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/B15007
606   $aNuclear Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H29048
606   $aRadiotherapy$3https://scigraph.springernature.com/ontologies/product-market-codes/H29056
606   $aPathology$3https://scigraph.springernature.com/ontologies/product-market-codes/H4800X
615  0$aEndocrinology.
615  0$aDiagnosis, Laboratory.
615  0$aNuclear medicine.
615  0$aRadiotherapy.
615  0$aPathology.
615 14$aEndocrinology.
615 24$aLaboratory Medicine.
615 24$aNuclear Medicine.
615 24$aRadiotherapy.
615 24$aPathology.
676   $a616.4
702   $aGiovanella$b Luca$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910300297103321
996   $aAtlas of Thyroid and Neuroendocrine Tumor Markers$91742915
997   $aUNINA